Herbas VPB

Print
EN | LT
LT - INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
EN - INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/08
A61K 39/39
A61K 39/395
A61P 35/00
European patent
(11) Number of the document 2608799
(13) Kind of document T
(96) European patent application number 11820530.1
Date of filing the European patent application 2011-08-23
(97) Date of publication of the European application 2013-07-03
(45) Date of publication and mention of the grant of the patent 2018-12-12
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2011/048823
Date 2011-08-23
PCT application publication
(87) Number WO 2012/027379
Date 2012-03-01
Priority applications
(30) Number Date Country code
376582 P 2010-08-24 US
Inventors
(72)
OKADA, Hideho, US
Grantee
(73) University of Pittsburgh - Of the Commonwealth System of Higher Education, 200 Gardner Steel Conference Center, Pittsburgh, PA 15260, US
Title
(54) INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
  INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
Last update date 2021-04-30